X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (56) 56
index medicus (54) 54
female (42) 42
gastroenterology and hepatology (42) 42
male (40) 40
gastroenterology & hepatology (37) 37
adult (36) 36
middle aged (33) 33
inflammatory bowel disease (25) 25
inflammatory-bowel-disease (25) 25
crohns-disease (23) 23
gene expression (23) 23
ulcerative colitis (22) 22
infliximab (20) 20
case-control studies (19) 19
ulcerative-colitis (19) 19
aged (17) 17
biopsy (16) 16
inflammatory bowel diseases (15) 15
intestinal mucosa - metabolism (15) 15
antibodies, monoclonal - therapeutic use (14) 14
inflammation (14) 14
colitis, ulcerative - drug therapy (13) 13
intestinal mucosa - pathology (13) 13
young adult (13) 13
colitis, ulcerative - pathology (12) 12
crohn's disease (12) 12
expression (12) 12
pathogenesis (12) 12
colon - pathology (11) 11
gene expression profiling (11) 11
therapy (11) 11
abridged index medicus (10) 10
adolescent (10) 10
colitis, ulcerative - genetics (10) 10
colon (10) 10
crohn disease - drug therapy (10) 10
crohn disease - genetics (10) 10
colitis, ulcerative - metabolism (9) 9
endoscopy (9) 9
gastrointestinal agents - therapeutic use (9) 9
genes (9) 9
intestine (9) 9
mucosa (9) 9
oligonucleotide array sequence analysis (9) 9
treatment outcome (9) 9
animals (8) 8
colon - metabolism (8) 8
crohn disease - metabolism (8) 8
intestinal mucosa - drug effects (8) 8
real-time polymerase chain reaction (8) 8
rna, messenger - genetics (8) 8
genetic aspects (7) 7
microbiota (7) 7
reverse transcriptase polymerase chain reaction (7) 7
biomarkers - metabolism (6) 6
colitis (6) 6
crohn disease - pathology (6) 6
crohns disease (6) 6
follow-up studies (6) 6
genotype (6) 6
immunohistochemistry (6) 6
mice (6) 6
patients (6) 6
research (6) 6
tumor necrosis factor-alpha - antagonists & inhibitors (6) 6
activation (5) 5
analysis (5) 5
anti-inflammatory agents - therapeutic use (5) 5
bacteria (5) 5
care and treatment (5) 5
cell biology (5) 5
down-regulation (5) 5
epithelial cells - metabolism (5) 5
inflammation - pathology (5) 5
inflammatory bowel diseases - drug therapy (5) 5
inflammatory bowel diseases - pathology (5) 5
infliximab treatment (5) 5
multidisciplinary sciences (5) 5
physiological aspects (5) 5
prognosis (5) 5
risk factors (5) 5
rodents (5) 5
science (5) 5
age (4) 4
anti-inflammatory agents, non-steroidal - therapeutic use (4) 4
autoantibodies (4) 4
biomarkers (4) 4
butyrates - metabolism (4) 4
cells, cultured (4) 4
child (4) 4
cohort studies (4) 4
colitis, ulcerative - microbiology (4) 4
colon - drug effects (4) 4
colonoscopy (4) 4
development and progression (4) 4
diagnosis (4) 4
dna microarrays (4) 4
enzyme-linked immunosorbent assay (4) 4
gastrointestinal diseases (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 08/2014, Volume 63, Issue 8, pp. 1275 - 1283
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10080, pp. 1672 - 1674
Journal Article
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 43 - 52
Journal Article
Journal Article
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 79 - 88
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2009, Volume 4, Issue 11, pp. e7984 - e7984
Background: Antimicrobial peptides (AMPs) protect the host intestinal mucosa against microorganisms. Abnormal expression of defensins was shown in inflammatory... 
SYSTEM | ILEUM | ULCERATIVE-COLITIS | BIOLOGY | COLON | MICE | INDUCTION | ALPHA-DEFENSIN EXPRESSION | ILEAL CROHNS-DISEASE | Inflammatory Bowel Diseases - drug therapy | Intestinal Mucosa - metabolism | Oligonucleotide Array Sequence Analysis | Anti-Inflammatory Agents - pharmacology | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Antimicrobial Cationic Peptides - pharmacology | Gene Expression Regulation | Crohn Disease - metabolism | Male | Inflammation | Mucous Membrane - metabolism | Immunohistochemistry - methods | Peptides - metabolism | Infliximab | Adult | Female | Inflammatory Bowel Diseases - microbiology | Immunohistochemistry | Medical research | Gastrointestinal diseases | Analysis | Genes | Medicine, Experimental | Neuropeptides | Research | Gene expression | Therapy | Inflammatory bowel diseases | Antimicrobial activity | Peptides | Epithelial cells | Mucosa | Genomes | Biology | Antiinfectives and antibacterials | Proteins | Infusion | Microorganisms | Intestine | Rodents | Gastroenterology | Antimicrobial peptides | Mathematical models | Colon | Bioinformatics | Immune system | Electrical engineering | Medical treatment | Computer engineering | Antimicrobial agents | Tumor necrosis factor-α | Patients | Computer science | Inflammatory bowel disease | Nutrition research | Crohn's Disease | Hypotheses | DNA microarrays | Antibiotics | Defensins | Biopsy | Morphology | Monoclonal antibodies | Bayesian analysis | Chemokines | infliximab | Data processing | Crohn's disease | Ileum | Polymerase chain reaction | Tumor necrosis factor-a | Digestive tract
Journal Article
Nature Communications, ISSN 2041-1723, 05/2017, Volume 8, Issue 1, p. 15384
Journal Article
Journal Article